Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (NCT07850713) titled 'Comparison of the Effect of Allopurinol Versus Febuxostat on Serum Uric Acid in Patients With Chronic Kidney Disease Associated With Hyperuricemia' on Sept. 24.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Single (Participant).
Primary Sponsor: Nishtar Medical University
Condition:
Hyperuricemia
Renal Insufficiency, Chronic
Intervention:
Drug: Febuxostat
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: May 13, 2026
Target Sample Size: 66
Countries of Recruitment:
Pakistan
To know mor...